ALIMERA SCIENCES, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 17 rows in 2016. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2016-10-11: Reporting owner Myers C. Daniel; Form 4; Security Employee Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-10-11: Reporting owner Holland David; Form 4; Security Employee Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-10-11: Reporting owner Green Kenneth; Form 4; Security Employee Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2016-10-11: Reporting owner Green Kenneth; Form 4; Security Employee Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2016-10-11 | Myers C. Daniel Director, Officer (CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −55,147 0 owned after | $1.33 | 2016-10-13 | |
| 2016-10-11 | Holland David Officer (SVP of Sales and Marketing) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −27,971 0 owned after | $1.33 | 2016-10-13 | |
| 2016-10-11 | Green Kenneth Officer (SVP & Chief Scientific Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,031 0 owned after | $1.33 exercise price | 2016-10-13 | |
| 2016-10-11 | Green Kenneth Officer (SVP & Chief Scientific Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −36,177 0 owned after | $1.33 exercise price | 2016-10-13 | |
| 2016-09-15 | EISWIRTH RICHARD S JR Officer (President and CFO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −51,471 0 owned after | $1.33 exercise price | 2016-09-16 | |
| 2016-06-23 | Pizzo Peter J. III Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.49 exercise price | 2016-06-27 | |
| 2016-06-23 | Largent James R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.49 exercise price | 2016-06-27 | |
| 2016-06-23 | Roberts Calvin W. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.49 exercise price | 2016-06-27 | |
| 2016-06-23 | BRADLEY GLEN Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.49 exercise price | 2016-06-27 | |
| 2016-06-23 | Kong Garheng Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.49 exercise price | 2016-06-27 | |
| 2016-06-23 | Halak Brian K Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.49 exercise price | 2016-06-27 | |
| 2016-06-23 | Brooks Mark J Director | 4 | Stock Option (Right to Buy) Derivative · Indirect · See FN | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.49 exercise price | 2016-06-24 | |
| 2016-01-04 | Ashman Philip Officer (SVP, EU Managing Director) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +125,000 125,000 owned after | $2.47 exercise price | 2016-01-06 | |
| 2016-01-04 | Holland David Officer (SVP of Sales and Marketing) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +125,000 125,000 owned after | $2.47 exercise price | 2016-01-06 | |
| 2016-01-04 | Green Kenneth Officer (SVP & Chief Scientific Officer) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +195,000 195,000 owned after | $2.47 exercise price | 2016-01-06 | |
| 2016-01-04 | EISWIRTH RICHARD S JR Officer (President and CFO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +275,000 275,000 owned after | $2.47 exercise price | 2016-01-06 | |
| 2016-01-04 | Myers C. Daniel Director, Officer (CEO) | 4 | Employee Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +450,000 450,000 owned after | $2.47 exercise price | 2016-01-06 |